Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bojungikki-tang for fatigue and muscle loss in advanced NSCLC patients on immune checkpoint inhibitors
KCT0006689Phase 2Completed
- Sponsor
- Korea Institute of Oriental Medicine
- Start
- May 2022
- Countries
- 1
01
Overview
A Phase 2 trial of Bojungikki-tang in non-small cell lung cancer (NSCLC), sponsored by Korea Institute of Oriental Medicine. Started May 2022; status: completed.
02
Drugs
Bojungikki-tang
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on KCT0006689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006689.